alpcot agro is a swedish limited liability company and was incorporated in 2006. the company’s objective is to generate an attractive total return on invested capital by acquiring and farming agricultural land in russia and in other cis member states.
Company profile
Ticker
CTCX
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ALPHA HEALTHCARE ACQUISITION CORP III
SEC CIK
CTCX stock data
Latest filings (excl ownership)
8-K
Carmell Announces $3.0 Million Private Placement
4 Apr 24
8-K
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
1 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
8-K
Entry into a Material Definitive Agreement
25 Mar 24
8-K
Carmell Corp Announces Addition of Dr. Bradley Calobrace to Scientific Advisory Board
16 Jan 24
8-K
Carmell Corp Announces Addition of Dr. Sean Kelishadi to Scientific Advisory Board
16 Jan 24
8-K
Carmell Corp Announces Addition of Dr. Gregory A. Buford to Scientific Advisory Board
16 Jan 24
8-K/A
Carmell Corp Announces Addition of Dr. Adam Rubinstein to Scientific Advisory Board
16 Jan 24
8-K/A
Carmell Corp Announces Addition of Dr. Jason D. Bloom to Scientific Advisory Board
16 Jan 24
8-K
Carmell Corp Announces Addition of Dr. Adam Rubinstein to Scientific Advisory Board
16 Jan 24
Latest ownership filings
SC 13G/A
SANDSTONE Asset Management
18 Apr 24
SC 13G/A
P SCHOENFELD ASSET MANAGEMENT LP
14 Feb 24
SC 13G/A
Antara Capital LP
14 Feb 24
SC 13G
METEORA CAPITAL, LLC
14 Feb 24
SC 13G/A
BALYASNY ASSET MANAGEMENT L.P.
14 Feb 24
SC 13G/A
Sculptor Capital LP
14 Feb 24
SC 13G/A
UBS OCONNOR LLC
12 Feb 24
SC 13G/A
Linden Capital L.P.
7 Feb 24
SC 13G
Newlin Investment Co 1, LLC
6 Feb 24
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
5 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.97 mm | 7.97 mm | 7.97 mm | 7.97 mm | 7.97 mm | |
Cash burn (monthly) | (no burn) | (no burn) | 3.82 mm | 1.46 mm | 37.69 k | |
Cash used (since last report) | n/a | n/a | 26.57 mm | 10.18 mm | 262.05 k | |
Cash remaining | n/a | n/a | -18.60 mm | -2.21 mm | 7.71 mm | |
Runway (months of cash) | n/a | n/a | -4.9 | -1.5 | 204.5 |
Institutional ownership, Q2 2023
85.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 38 |
Opened positions | 9 |
Closed positions | 13 |
Increased positions | 8 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 117.49 bn |
Total shares | 16.48 mm |
Total puts | 0.00 |
Total calls | 237.47 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Periscope Capital | 1.68 mm | $12.10 bn |
P Schoenfeld Asset Management | 1.49 mm | $15.31 bn |
Ubs Oconnor | 1.49 mm | $15.31 bn |
Linden Advisors | 1.22 mm | $8.82 bn |
SANDSTONE Asset Management | 1.02 mm | $10.01 mm |
Integrated Core Strategies | 960.83 k | $0.00 |
Millennium Management | 957.23 k | $9.86 bn |
Linden Capital | 849.00 k | $0.00 |
JPM JPMorgan Chase & Co. | 821.67 k | $8.48 bn |
Aristeia Capital | 692.34 k | $7.13 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Dec 23 | Kathryn Gregory | Common Stock | Buy | Acquire P | Yes | No | 3.9351 | 739 | 2.91 k | 6,727 |
15 Dec 23 | Anderson David W | Common Stock | Buy | Acquire P | Yes | No | 3.9351 | 739 | 2.91 k | 6,727 |
15 Dec 23 | Patrick A Sturgeon | Common Stock | Buy | Acquire P | Yes | No | 3.9351 | 739 | 2.91 k | 6,727 |
14 Dec 23 | Bryan J. Cassaday | Common Stock | Buy | Acquire P | No | No | 3.5 | 440 | 1.54 k | 1,940 |
14 Dec 23 | Kathryn Gregory | Common Stock | Buy | Acquire P | Yes | No | 3.6119 | 391 | 1.41 k | 5,988 |
14 Dec 23 | Anderson David W | Common Stock | Buy | Acquire P | Yes | No | 3.6119 | 391 | 1.41 k | 5,988 |
14 Dec 23 | Patrick A Sturgeon | Common Stock | Buy | Acquire P | Yes | No | 3.6119 | 391 | 1.41 k | 5,988 |
2 Jan 23 | Rajiv Shukla | Common Stock | Grant | Acquire A | No | No | 0 | 14,347 | 0.00 | 48,526 |
23 Sep 21 | Kathryn Gregory | Common Stock | Other | Acquire J | No | No | 0 | 0 | 0.00 | 74,385 |
23 Sep 21 | Anderson David W | Common Stock | Other | Acquire J | No | No | 0 | 0 | 0.00 | 63,472 |
News
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
23 Apr 24
12 Health Care Stocks Moving In Thursday's Intraday Session
4 Apr 24
Carmell Announces $3M Private Placement Of ~1,333,333 Shares Of Its Common Stock In A Private Placement At A Price Of $2.25 Per Common Share
4 Apr 24
12 Health Care Stocks Moving In Friday's Intraday Session
15 Mar 24
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
26 Feb 24
Press releases
Carmell Announces Successful Closing of $3.0 Million Private Placement
11 Apr 24
Carmell Announces $3.0 Million Private Placement
4 Apr 24
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
27 Mar 24
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
20 Mar 24
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
26 Feb 24